Charles-André (“CAB”) Brouwers has over thirty years of experience as a strategy consultant to pharmaceutical companies and is an expert in the generic industry.
He is currently the founder and managing partner of Galileo Life Sciences, a boutique strategy firm, and a Managing Director of Galileo Global Securities, a private market investment bank. He is also the President of the Belgian American Chamber of Commerce. Formerly, he was Senior Partner and Managing Director of the Healthcare Practice of the Boston Consulting Group, where he created and led the Generic practice for over 15 years.
